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T lymphocytes. Image from Johnson Space Center Roundup. CC

Honey, are these my kids?
My hands?
My organs?

							My cells?
By Anoohya Muppirala
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From culture to cells,
memory spans multiple levels
of our lives. Recent advances in
neuroimmunology suggest that
tapping
into
“immunological
memory” or the memory of our
microscopic cells, may contain
the answers to protecting against
higher order cognitive memory
decline that occurs in autoimmune
disease, stress…and aging.
People often say that
memory makes us who we are—
and this couldn’t be closer to the
truth. At a macroscopic level,
cultural memory describes how we
feel connected to our families and
those around us. It is defined as a
cultivation of historical experiences
that are passed through generations
and ultimately constitute the
“blood” of the people1.
memory
is
However,
not only how we identify with a
community through our collective
experiences. Cognitive memory
describes how we go about
our everyday lives and how we
remember and know our unique
place in the world—our home, our
name, our identity—and without it,
everything can get a bit jumbled
and confusing.
Interestingly, it turns out that
within our blood—our cells have
memory too. Now, scientists often
frown upon anthropomorphizing,
but, rest assured,
hardly any
creative license is being taken. In
her text, Human Physiology: From
Cells to Systems, Professor Lauralee
Sherwood defines “memory” as
the ability to encode and store
information from an experience
and retrieve that information when
needed in the future2. Well, this
description perfectly describes how
immune system cells in our bodies
protect us from foreign pathogens
24/7.
The immune system is
the body’s defense to harmful
pathogens, and after fighting
off an infection for the first time,

specific immune cells remember
the pathogen and prevent any
recurring infections. This is known
as immunological memory. The
cells that are crucial players, known
as memory B and T lymphocytes,
are long-lived, protect the host,
and make replicates of themselves
when a familiar pathogen tries to
invade the body3. Essentially, the
body has a molecular and cellular
profile that defines its own intrinsic
culture; the memory lymphocytes
of the immune system imprint each
infection as an experience and then
pass on the information to new
generations of naïve immune cells
so they can more readily prevent
the infection from happening again.
Immunological Memory:
“Essentially, the body has
a molecular and cellular
profile that defines its own
intrinsic culture; the memory
lymphocytes of the immune
system imprint each infection
as an experience and then
pass on the information to
new generations of naïve
immune cells so they can more
readily prevent the infection
from
happening
again.”

But sometimes, these cells get
confused with their own identity and
their memory marks components
of the body as foreign—otherwise
known as autoimmunity. When
our immune cells can no longer
tell self from non-self, it can lead to
problems with a lot higher stakes.
Imagine when our immune cells see
the brain as foreign—the center
of our thoughts and every day
function? Now we have an internal
fight where cellular memory gone
wrong is putting our memory that
defines us and how we view the
world at risk too.

Multiple-Sclerosis is not
MOG-nificent
Multiple Sclerosis (MS) is a
chronic, autoimmune disease of
the central nervous system, which
is comprised of the brain and
spinal cord. MS is a leading cause
of disability in young adults and
affects more than an estimated
2.3 million people worldwide4.
Curiously, over the past half century,
MS has become increasingly more
prevalent in women, with diagnostic
rates reaching up to three times
higher than men. Physiologically,
MS symptoms range from slurred
speech, tremors, and coordination
to problems with memory and
concentration.
When taking a closer
look, the underlying condition is
due to circulating immune cells
leaving the blood and invading
brain tissue. The culprits—CD4+T
lymphocytes—cross layers of cells
that line the blood vessel and
serve as the physical border to the
brain. Subsequently, they enter
the environment of brain tissue…
and things get interesting. See, the
brain is defined as an “immuneprivileged” region, meaning that
the brain environment is supposed
to be separate from contact with
immune cells. During development,
B and T immune cells reside in
an isolated region of the body in
order to be tested with samples
that mimic body tissues. This way,
the immune cells that react to the
body tissue are safely eliminated,
allowing only non-reactive immune
cells to enter the blood and
circulate through the body looking
for foreign invaders. Since these
immune cells are supposedly never
going to interact with brain tissue,
the immune cells are never tested
with it.
One component of the brain
that is not tested with B and T cells
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is the molecule known as myelin
oligodendrocyte
glycoprotein
(MOG), which makes up the fatty
tissue, myelin, that wraps around
neuron projections to help facilitate
signaling (Imagine a rubber
coating insulating the cord from a
phone charger to the wall). When
seen by invading T cells, MOG
looks unfamiliar, and is therefore
processed as harmful. The T cells
then release signals to recruit B
cells and other immune cells to
attack the neurons, which results
in progressive neuron damage and
impaired overall nervous system
function.
The immune system is
clearly incredibly complex. Scientists have been scratching
their heads trying to understand
how cells handle the foreign
environment of the brain in order to
develop MS treatment to suppress
reactivity. Turns out, mice have
played a leading role in answering
some of these difficult questions.
Surprisingly, these common household pets have a remarkably
similar immune system structure to
humans, including the function of B
and T cells5. Along these lines, we
have a mouse model for Multiple
Sclerosis (EAE) to thank for the
advancements in therapeutic MS
treatments that have been made in
recent years. Interestingly, the EAE
model has revealed that targeting
the invading CD4+ T cells is not
nearly as effective in minimizing
symptoms as depleting B cells. B
cell depletion therapy has shown
promising results for MS patients,
because it eliminates B cells from
being able to develop into memory
cells. With every infection, B cells
directly become plasma cells,
which secrete antibodies—proteins
that target the infecting pathogen.
However, some of these B cells also
become memory B cells, which
remember the same antibody that
the plasma cells are producing but
don’t release it. These memory B
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Fig. 2: Process of B cell response during primary and recurrent infection. After
first infection, B cells become plasma cells that secrete antibodies (Y shaped
proteins) to target the infectious pathogen. At the same time, memory B cells
that remember the pathogen are being created and rest quietly. Then, if a
recurrent or second infection occurs by the same pathogen, the memory B cells
respond quickly and become plasma cells that can secrete antibodies that are
even better than the previous ones, using the information from the first infection. Designed by Anoohya Muppirala.

cells then turn into plasma cells
that end up secreting even better
antibodies to target the pathogen
more effectively if it tries to infect
the body again. So, in MS, memory
B cells are a problem because
they keep secreting antibodies
that target MOG. However, B cell
depletion therapy prevents these
memory B cells from forming in
the first place as well as preventing
B cells from producing more
generations of memory B cells that
will do the same6 (Fig. 2).
In further support of targeting
memory
cells,
the
immunosuppressive drug alemtuzumab has been revealed to
be particularly promising as a
therapeutic option. Alleviating an
initial immune response in MS can
be accomplished by suppressing
the reactive immune cells, but MS
patients often suffer relapse, where
their immune system is triggered
repeatedly. This component often
makes MS devastating, because
each time a relapse occurs, the

body’s ability to repair neurons
diminishes. Alemtuzumab inhibits
relapse because the drug slows
down the recovery of memory B
cells after wiping out circulating
immune cells7. This suppresses
the ability of the memory cells
to react immediately to MOG,
buying time before new immune
cells are exposed to MOG again
in the brain. So essentially, new
evidence suggests that targeting
immunological memory may be a
powerful MS treatment —perhaps
saving one more patient from losing
their cognitive level of memory.

NMDA Receptor
Antibody Encephalitis:
B a dear and turn off the
Plasma cells

35-year-old Jane* sat up in
her bed and blinked. She smiled,
and then blinked again…slowly,
relishing the fine control she had
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over her eyelids. She touched her
bed, soaking in the warm remnants
of her body heat on the covers
with her fingers. One year ago, she
wouldn’t have remembered where
she was or been able to appreciate
the feeling of being still due to
her recurrent seizures and lapses
in memory. Doctors even saw that
her MRI revealed a striking loss of
normal hippocampal volume—a
region of the brain critical for
memory. But after switching
from her Rituximab treatment
to another immunosuppressant
drug, bortezomib, Jane went
from bed ridden to functioning
independently in little over a year!
And the treatment could not have
come at a better time. As her days
progressed in the hospital prior to
bortezomib, Jane’s ability to form
new memories (anterograde) had
been fading, and her recollection
of old memories (retrograde) had
also begun to weaken.
In a similar case, another
comparably aged female, Franny*,
suffered from memory loss, muscle
pain due to nerve dysfunction
(myalgia), and involuntary muscle
movement through her face and
upper limbs on her right side.
Franny’s situation also left her bedridden. What was perhaps most
striking about Franny’s condition
was that she also suffered from
behavioral changes. After four
weeks of bortezomib treatment,
however, Franny was able to return
home and regain control over
much of her voluntary movement
as well as both retrograde and
anterograde memory8.
Both of these cases reveal
remarkable recovery—so what
gives? By the looks of the situation,
it is not a stretch to infer that the
time spent in the hospital for these
two women was fighting to not
lose themselves. While they may
not have known each other, Jane
and Franny had a huge thing in
common: they both were battling

an autoimmune condition known
as NMDA receptor antibody
Encephalitis. NMDA (N-methyl-daspartate) receptors are expressed
by neurons, especially in the
hippocampus, which, again, is a
region of the brain that is critical
to memory formation and storage.
In patients with this condition,
memory B cells develop antibodies
that target the NMDA receptors
on these neurons, preventing
NMDA from binding and inhibiting
signaling.
Subsequently,
the
connections between neurons
weaken because of lack of
activation,
and
hippocampal
volume and memory loss follow.
Rituximab is a drug that targets
a protein found on the surface
of memory B cells before they
become antibody-secreting plasma
cells. These plasma cells that
actually secrete the anti-NMDA
receptor antibody do not express
the protein required for Rituximab
to shut it down. Bortezomib on
the other hand, directly targets the
plasma cells, preventing antibody
production8.
What is curious, is that one
would think that inhibiting memory
B cells would inhibit plasma cell
formation and therefore prevent
antibody production…so wouldn’t
Rituximab and Bortezomib be
redundant? Well, it turns out that
long-lived plasma cells exist in
our bodies following an immune
response, and they continually
secrete the pathogen-specific
antibody even after the first
infection has ceased (way to
complicate figure 2, right?). So,
patients treated with Rituximab
may not be producing as many new
memory B cells, but their plasma
cells formed before the treatment
are still producing the NMDA
receptor antibody, rendering the
drug less effective than Bortezomib.
Ironically, this continual baseline
level of antibody production from
long-lived plasma cells is called

protective immunity, because in
healthy individuals, it helps prevent
recurrent infection by immediately
targeting pathogens that try to reenter the body. But in Jane and
Franny’s cases, protective immunity
actually caused their symptoms—
because their bodies were trying to
protect them from their own brains.

*Patient names changed to protect
identity

I’m stressed, I’m sick,
I’m inflamed …what’s
an antibiotic going
to do?
Many people can relate
to the experience of physically
getting a cold or feeling ill during
an ongoing period of stress. It
comes as no surprise that this
is due to the immune system
being compromised, rendering
an individual more susceptible
to infection. But what is perhaps
alarming, is that individuals who
suffer from abnormally ongoing
periods of stress or chronic
stress, can suffer from reduced
hippocampal size and memory loss.
In fact, even more broadly, chronic
stress has been established as
a strong risk factor for numerous
mental health conditions including
anxiety and depression. While
research is ongoing regarding the
exact biological and environmental
factors that explain stress related
cognitive
impairment,
recent
evidence is demonstrating that
immune system dysfunction is
implicated in chronic stress-linked
memory loss.
Swinging back to the
mouse, researchers have been able
to identify a lead on how immune
dysfunction may be directly
impairing memory. Scientists have
utilized a chronic stress model
in mice known as the repeated

38

SCIENTIFIC KENYON

Fig. 3 Animal and rodent studies are a constant
source of debate. But rodent models have
significantly added to our understanding
of various diseases and are contributing to
enhancing the quality of life of many
people around the world[9].

and memory10. So, while stress is
unavoidable during finals week, try
not to get sick, because you know
what they say—a healthy immune
system keeps the memory intact…
ok, perhaps not a catchy phrase,
but it can be worked on.

As the years go on
the memory (what
type?) fades

social defeat (RSD) model. It
has been shown that individuals
experiencing chronic stress often
demonstrate persistent emotional
and cognitive dysregulation, which
the RSD model recapitulates in
mice. To induce stress, male mice
are essentially exposed to an
emotional stressor (an aggressive
male mouse) in intervals repeatedly
for about a week and then given
various spatial memory tasks10.
Not only did the mice
perform poorly on the memory
tasks following the stress protocol,
but fascinatingly, brain slices from
the mice revealed high levels of
inflammatory proteins, which are
secreted by reactive immune cells,
in the limbic region of the brain—a
center involved in emotion. More
specifically, the inflammatory
proteins, along with B, T, and
other immune cells, were largely
accumulated in the hippocampus.
One of these immune
cells, the macrophage, is known
as a phagocyte, for it functions
in consuming cellular debris and
pathogens. When macrophages
enter the brain environment,
they respond to the inflammatory
signals and attack hippocampal
neurons—damaging neural circuits
and signaling. In this condition,
with the gathering of immune
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cells and inflammatory signals,
the hippocampus is said to be
inflamed. In this state, the rate
of mature hippocampal neuron
growth is severely hindered from
damage, which was indeed found
with the RSD model mice.
After identifying that the
RSD mice had inflamed hippocampi,
researchers wanted to investigate
whether targeting the inflammation
could protect against memory
impairment. Therefore, prior to
starting the stress protocol, RSD
mice were administered a common
antibiotic, Minocycline. This drug
broadly suppresses immune cells.
On average, RSD mice performed
better on memory tasks, and
hippocampal slices revealed more
mature hippocampal neurons and
reduced inflammation.
Ultimately, the idea that
chronic stress can affect brain
function may not be a new one.
However, the immune system
has been underappreciated in its
direct role in targeting focused
regions of the brain related to
memory and emotion following
exposure to stressors. The fact that
Minocycline, a common antibiotic,
can reduce stress-related memory
loss, supports the model that
the immune system is intimately
involved in cognitive function

In
the
first
grade,
Carla* believed her biggest
accomplishment
was
putting
her engineering skills to use by
creating a Velcro attachment for
her grandpa’s glasses. This way, he
could keep his glasses on his shirt
whenever he was done using them.
Otherwise, odds were, he would
leave them on a counter in the
house somewhere and be unable
to recollect where he kept them.
Whenever Carla would find the
glasses for him, her grandpa would
take them and exasperatedly
apologize. “My memory isn’t what
it used to be. Thanks kiddo.”
While many people may
relate to having a loved one
whose memory just isn’t as sharp
as it used to be, researchers have
identified that the same can be
said about memory T cells over
time. Turns out, dysregulation in
immunological memory is not only
triggered in autoimmune diseases
or psychosocial stress, but is also a
normal aspect of aging.
How? Well, interestingly,
(and a bit of a disclaimer), all immune cells don’t have to invade the
brain by crossing a physical barrier.
Everyone has a pool of memory T
cells that are constantly lined up in
certain areas of brain tissue. These
T cells would be reactive to brain
tissue, but they are well contained
and regulated by the tissue cells
surrounding them. However, as
aging occurs, the regulation by
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these tissue cells worsens, and
more inflammatory proteins are
produced by the memory T cells.
These inflammatory proteins cause
the increase in chemical signals
that have been linked to cognitive
decline11.
acknowledging
Now,
that aging changes the brain environment seems obvious, so where
do we go from here? How can we
pick apart the brain environment to
understand causes of age-related
cognitive decline? Forewarning
of deja vu, but another mouse
model helped researchers start
attacking these questions. Essentially, scientists examined the
differences in the inflammatory
protein production by memory T
cells in brain tissue in both young
and aged mice.
Furthermore,
to address memory decline, the
researchers investigated levels of
specific molecules that promote
hippocampal neuron growth and
signaling.
As suspected, memory T
cells in aged mice produced higher
levels of inflammatory proteins than
the memory T cells in the young
mice. Furthermore, aged mice had
lower levels of hippocampal growth
factors, which explains impaired
cognitive memory11.
So now that there is
evidence demonstrating a difference in memory T cell function
within the brain based on age, are
there any therapeutic possibilities
to reduce age-related cognitive
decline? To explore this idea, the
researchers transplanted memory
T cells from aged mice into other
identically aged mice that had
impaired memory. Additionally,
these aged mice receiving the
transplant had all of their immune
cells depleted. So, the transplanted
memory T cells had to replicate
in a new environment free of the
influences of other immune cells.
Then,
researchers
conducted
spatial memory tasks and examined

hippocampal tissue. Much to their
astonishment, the transplanted
aged mice had improved memory,
and they also expressed higher
levels of hippocampal growth cues!
Now, we all know the itching
question here: Why would aged
memory T cells be able to restore
memory impairment after being
transplanted into identically aged
mice that had no immune cells?
Curiously, upon a closer look,
researchers identified that the
reason the transplant may have
been so successful is because
the sterile, immune cell-free
environment
encouraged
the
transplanted aged memory T cells
to produce signals similar to those
found in young mice[11]. So aged
memory T cells are capable of
reversing age-related cognitive
decline if they can be “tricked”
into thinking they are young again.
Looks like the desire to be youthful
has some potential therapeutic
merit—down to the cellular level.
*character name of anecdote

Let’s Get Natural
Let’s bring the discussion
back to the way beginning where
cultural memory came up. A large
part of what makes a community

bond is, well…food. It’s a vicious
cycle: at every turn of a year, it feels
as though society is entertaining
a new diet trend, which is
subsequently
invalidated
by
research, and then the trend finds a
new focus—and the cycle repeats.
Turns out though, that some of
these trending diets and food
crazes may actually benefit and
protect against memory decline!
Specifically, multiple components
found in natural foods possess antiinflammatory properties, meaning
that they help regulate the immune
system to prevent inappropriate
reactivity.
By
minimizing
inflammation in the brain, these
compounds have been implicated
in protecting against memory loss.
One trend that has gained
popularity in recent years is the
ketogenic diet. Individuals on this
diet follow a plan of consuming
minimal carbohydrates and high
amounts of fats. Because ketogenic diets have been acclaimed
to
provide
health
benefits,
researchers sought to ask whether
the ketogenic diet could protect
against
inflammation-mediated
memory impairment. To test this
idea, mice were fed a ketogenic
diet and then immunized to
mount an immune response. After
conducting memory tasks, the mice

Berries on pxhere
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on the ketogenic diet revealed
higher scores than the immunized
mice on a non-ketogenic diet12.
While much has to be done
to define an exact mechanism
by how this diet may protect or
enhance memory, the suggested
link between highly fatty foods and
memory is interesting to note.
Along similar lines, berries
have long been praised for their
anti-inflammatory properties, and it
turns out that a specific compound
found in these fruits, called
anthocyanins, has neuroprotective
effects. Using an Alzheimer’s mouse
model, researchers found that
administering anthocyanins provided protection against memory
decline13. So, funnily enough, the
age-old adage from our parents
that “eating our fruits and veggies
is good for our health” holds true—
and just maybe, the all-natural food
crazes are not as crazy as we think.
***
From neurodegenerative diseases,
to stress, to aging—immunological
memory plays an important role in
the cognitive memory dysfunction
that often occurs in these various
conditions. While science has
a ways to go in the journey of
untapping the power of the immune
system, we are making way in
understanding how the memory of
our immune cells can be harnessed
to prevent the attack of our own
bodies on our brains and ultimately
…our minds.
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